BC
BioCardia, Inc.
BCDA · NASDAQ
$1.04 -1.89% (-$0.02)
1M -3.70%
Market Cap $15.8M
P/E Ratio -
Div. Yield -
ROE 569.36%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
27 /100
Expensive P/B 5.84x
PEG N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 43.23%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 154.34%
ROIC 246.91%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 2.09x
Debt/Equity 0.11x
Debt/Assets N/A
Stability
60 /100
Moderate EPS volatility 24.83%
Beta 0.49x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BCDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter A. Altman
Employees
17
Headquarters
Sunnyvale
Upcoming events
11 NOV
Earnings
Upcoming earnings report